• Contact Us
  • Indexing
  • Submit Manuscript
  • Open Access
  • Journals
  • Home
  • ISSN: 2373-9258
    Early Online
    Volume 6, Issue 1
    Review Article
    Janina Veit* and Olav Lapaire
    Preeclampsia, a severe pregnancy associated disorder, is often complicated by impaired fetal growth or preterm delivery and can be associated with long-term maternal mortality and morbidity. Women with a history of preeclampsia have an increased risk of cardiovascular disease later in life. This may because by both postpartum endothelial dysfunction and asymptomatic structural cardiac alterations. Therefore, lifelong monitoring of cardiovascular risk factors following preeclampsia is advisable.
    Rui Yang and Ying Wang*
    Assisted reproductive technologies (ART) have helped solving infertility problem and improved greatly in recent years. The key to normal embryo implantation and pregnancy lies in the preferential invasion of early pregnancy trophoblastic cells into the uterine wall. The trophoblast cell function of in vitro fertilization and embryo transfer (IVF-ET) group in first trimester is different from natural conceived ones in proliferation, invasion, apoptosis and vascular development.
    Case Report
    Xiao-Xiao Xie, Xiang-Fei Meng, Zhi-Ying Gao*, Yan-Qin You, Hong-Hui Zhou, and Shu-Juan Wang
    HELLP syndrome with liver subcapsular hematoma is a rare but catastrophic complication during pregnancy that results in high morbidity for both the mother and fetus. Two types of therapy have been established. One type is surgical therapy, and the other is conservative treatment under intense monitoring. It has been reported that surgical therapy may increase maternal loss due to the large trauma caused by surgical intervention. However, pure conservative treatment does not seem to decrease the risk of hematoma spontaneous rupture which causes over 60% mortality. Herein, we report a case with a 27-year-old patient. She accepted conservative treatment combined with transarterial embolization (TAE), which led to a good result. We also review relevant literature and discuss this therapy.
  • Recent Research
  • Telehealth Technologies - Are They Useful or Simply Risky and Costly for Patients with Hypertension?
    Readmore...

    Telehealth Technologies - Are They Useful or Simply Risky and Costly for Patients with Hypertension?
    Readmore...

    JSciMed Central Peer-reviewed Open Access Journals
    10120 S Eastern Ave, Henderson,
    Nevada 89052, USA
    Tel: (702)-751-7806
    Toll free number: 1-800-762-9856
    Fax: (844)-572-4633 (844-JSCIMED)
    E-mail: hypertension@jscimedcentral.com
    1455 Frazee Road, Suite 570
    San Diego, California 92108, USA
    Tel: (619)-373-8720
    Toll free number: 1-800-762-9856
    Fax: (844)-572-4633 (844-JSCIMED)
    E-mail: hypertension@jscimedcentral.com
    About      |      Journals      |      Open Access      |      Special Issue Proposals      |      Guidelines      |      Submit Manuscript      |      Contacts
    Copyright © 2016 JSciMed Central All Rights Reserved
    Creative Commons Licence Open Access Publication by JSciMed Central is licensed under a Creative Commons Attribution 4.0 International License.
    Based on a work at https://jscimedcentral.com/. Permissions beyond the scope of this license may be available at https://creativecommons.org/.